Nextleaf Solutions Past Earnings Performance
Past criteria checks 3/6
Nextleaf Solutions has been growing earnings at an average annual rate of 27.4%, while the Pharmaceuticals industry saw earnings growing at 26.2% annually. Revenues have been growing at an average rate of 57.6% per year. Nextleaf Solutions's return on equity is 21.5%, and it has net margins of 9%.
Key information
27.4%
Earnings growth rate
37.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 57.6% |
| Return on equity | 21.5% |
| Net Margin | 9.0% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Nextleaf Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 10 | 1 | 2 | 0 |
| 30 Sep 23 | 8 | 0 | 2 | 0 |
| 30 Jun 23 | 6 | -1 | 2 | 0 |
| 31 Mar 23 | 5 | -3 | 2 | 0 |
| 31 Dec 22 | 4 | -3 | 3 | 0 |
| 30 Sep 22 | 4 | -3 | 3 | 0 |
| 30 Jun 22 | 5 | -5 | 3 | 0 |
| 31 Mar 22 | 4 | -5 | 3 | 0 |
| 31 Dec 21 | 3 | -5 | 3 | 0 |
| 30 Sep 21 | 3 | -5 | 3 | 0 |
| 30 Jun 21 | 2 | -6 | 3 | 0 |
| 31 Mar 21 | 2 | -5 | 3 | 0 |
| 31 Dec 20 | 2 | -6 | 4 | 0 |
| 30 Sep 20 | 1 | -6 | 4 | 0 |
| 30 Jun 20 | 0 | -6 | 5 | 0 |
| 31 Mar 20 | 0 | -6 | 5 | 0 |
| 31 Dec 19 | 0 | -10 | 7 | 0 |
| 30 Sep 19 | 0 | -9 | 6 | 0 |
| 30 Jun 19 | 0 | -8 | 5 | 0 |
| 31 Mar 19 | 0 | -6 | 4 | 0 |
| 31 Dec 18 | 0 | -3 | 2 | 0 |
| 30 Sep 18 | 1 | -2 | 2 | 0 |
| 30 Jun 18 | 0 | -2 | 1 | 0 |
| 30 Sep 17 | 0 | -1 | 0 | 0 |
Quality Earnings: OILS has a large one-off gain of CA$378.2K impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: OILS became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OILS has become profitable over the past 5 years, growing earnings by 27.4% per year.
Accelerating Growth: OILS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: OILS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22%).
Return on Equity
High ROE: OILS's Return on Equity (21.5%) is considered high.